REDACTED
EXHIBIT 10.313
**CONFIDENTIAL TREATMENT REQUESTED**
AMENDMENT
This agreement is entered into by and between CHIRON CORPORATION, a
Delaware corporation ("Chiron") and GEN-PROBE INCORPORATED, a Delaware
corporation ("Gen-Probe").
RECITALS
WHEREAS, Chiron and Gen-Probe signed an agreement on June 11, 1998 with
respect to Products for the Blood Screening Field and [PROVISION ASSIGNED]
(the "Agreement").
WHEREAS, the parties desire to amend the Agreement as set forth in this
Amendment in order to facilitate the purposes of the Agreement.
AGREEMENT
In consideration of the facts recited above and the mutual commitments
set forth below, the parties agree as follows:
1. Article 14 of the Agreement shall be and is hereby amended to
read as follows:
"In consideration for the rights originally granted to Chiron
by this Agreement with respect to TMA and HPA, Chiron shall pay to
Gen-Probe, [PROVISION ASSIGNED], the following nonrefundable amounts
upon the occurrence of each event set forth below:
(1) [CONFIDENTIAL TREATMENT REQUESTED]; and
(2) [CONFIDENTIAL TREATMENT REQUESTED]:
(a) (i) [CONFIDENTIAL TREATMENT REQUESTED]
(b) [CONFIDENTIAL TREATMENT REQUESTED].
(3) [CONFIDENTIAL TREATMENT REQUESTED].
(4) [CONFIDENTIAL TREATMENT REQUESTED].
2. Except as expressly amended above, the Agreement shall remain
in full force and effect.
By the signatures of their authorized officers below,
Gen-Probe and Chiron adopt this amendment as of December 7, 1999.
CHIRON CORPORATION GEN-PROBE INCORPORATED
By /s/ ▇▇▇▇▇ ▇▇▇▇▇ By /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
---------------- ----------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: President, Blood Testing President and
Chiron Chief Executive Officer
Page 2 of 2
